In Vitro Activity of Clarithromycin against Intracellular Helicobacter pylori

AUTOR(ES)

Piccolomini, Raffaele

FONTE

American Society for Microbiology

RESUMO

The in vitro intracellular effect of clarithromycin, amoxicillin, metronidazole, lansoprazole, and rifabutin, tested at concentrations corresponding to one times the MIC, two times the MIC, and four times the MIC, was evaluated against an invasive Helicobacter pylori strain. At four times the MIC, clarithromycin showed an early bactericidal effect within 4 h of incubation and, in determining the complete killing within a 16 h-incubation period, lansoprazole and rifabutin showed comparable activity, yielding bactericidal activities within 4 and 8 h of incubation, respectively. Amoxicillin and metronidazole showed bacteriostatic activity only.

Documentos Relacionados

• In vitro antagonistic activity of Lactobacillus casei against Helicobacter pylori
• In Vitro Activities of Linezolid Alone and in Combination with Amoxicillin, Clarithromycin, and Metronidazole against Helicobacter pylori
• In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori.
• Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
• In vitro activities of new quinolones against Helicobacter pylori.